Risk for intravesical recurrence of bladder cancer stratified by the results on two consecutive UroVysion fluorescence in situ hybridization tests: a prospective follow-up study in Japan.

Atsushi IkedaTakahiro KojimaKoji KawaiShiro HinotsuNaoto KeinoKenichiro ShigaHideaki MiyakeYasuyoshi MiyataYutaka EnomotoFumitaka ShimizuSatoshi AnaiHideyasu MatsuyamaChieko SuzukiYusuke KanimotoKeisuke ShigetaSeiji NaitoHideyuki AkazaHiroyuki Nishiyama

Published in: International journal of clinical oncology (2020)

Our data confirmed the effectiveness of two consecutive UroVysion tests in predicting intravesical recurrence after TURBT. Further prospective studies would help determine an appropriate interval for cystoscopy follow-up.

Keyphrases

muscle invasive bladder cancer
randomized controlled trial
urinary tract
systematic review
electronic health record
single molecule
free survival
case control
deep learning
data analysis